Crypto’s monetary policy-driven suffering this year has only worsened from the fallout of one of its biggest exchanges, and figureheads.
The stock market has mostly ignored it.
From its hig
Crypto’s monetary policy-driven suffering this year has only worsened from the fallout of one of its biggest exchanges, and figureheads.
The stock market has mostly ignored it.
From its hig
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Beijing is holding back its required green light for mergers that involve American companies as a technology war with Washington intensifies.
All those tech layoffs are starting to show up in employment statistics, but they still show little sign of spreading to other sectors.